Abstract-In brain, the regulatory mechanism of the endothelial reactivity to nitric oxide and endothelin-1 may involve Ca 2ϩ , cytoskeleton, and vasodilator-stimulated phosphoprotein changes mediated by the cGMP/cGMP kinase system. 1 Endothelium of human brain capillaries or microvessels is used to examine the interplay of endothelin-1 with the putative vasorelaxant 2-arachidonoyl glycerol, an endogenous cannabimimetic derivative of arachidonic acid. This study demonstrates that 2-arachidonoyl glycerol counteracts Ca 2ϩ mobilization and cytoskeleton rearrangement induced by endothelin-1. This event is independent of nitric oxide, cyclooxygenase, and lipoxygenase and is mediated in part by cannabimimetic CB1 receptor, G protein, phosphoinositol signal transduction pathway, and Ca 2ϩ -activated K ϩ channels. The induced rearrangements of cellular cytoskeleton (actin or vimentin) are partly prevented by inhibition of protein kinase C or high levels of potassium chloride. The 2-arachidonoyl glycerol-induced phosphorylation of vasodilatorstimulated phosphoprotein is mediated by cAMP. These findings suggest that 2-arachidonoyl glycerol may contribute to the regulation of cerebral capillary and microvascular function. (Circ Res. 2000;87:323-327.)
A n endogenous cannabinoid originally isolated from gut and brain, 2-arachidonoyl glycerol (2-AG), can be generated and released from blood and vascular cells. [2] [3] [4] 2-AG is an intrinsic physiological ligand for the cannabinoid CB1 receptor 3 ; these receptors are expressed in the brain and peripheral organs including vessels, platelets, and macrophages. 4 -7 2-AG induces a rapid transient elevation in intracellular Ca 2ϩ through activation of the CB1 receptor in NG108-15 cells 8 ; this response is independent of cyclooxygenase and lipoxygenase. 4, 8 2-AG also inhibits adenyl cyclase in mouse spleen cells and twitch responses in vas deferens. 4 This novel bioactive lipid causes hypotension that may be attributed to its hyperpolarizing properties. 9 It is suggested that induction of 2-AG release in endothelium occurs in parallel to nitric oxide (NO) and involves activation of cholinergic receptors. 10 Previous studies in vivo and in vitro demonstrated that NO, the most effective endotheliumderived relaxing factor (EDRF) and endothelial-derived hyperpolarizing factor (EDHF), 11 may have a close functional relationship with the potent vasoconstrictor endothelin-1 (ET-1) in regulating the endothelium-dependent capillary and microvascular responses in the brain. 1 ET-1 induces the production of NO, which, in turn, reduces the secretion of ET-1. NO can also affect the binding of ET-1 to its receptor [12] [13] [14] and alter the ET-1-stimulated Ca 2ϩ mobilization and cytoskeleton arrangement in the endothelium derived from human cerebral capillaries (HBECs) and microvessels (HBMECs). This effect is mediated by the cGMP/ cGMP kinase system and is associated with phosphorylation of vasodilator-stimulated phosphoprotein (VASP). The results of the present study indicate that endothelium possesses the intrinsic machinery required to balance the effects of NO and ET-1 and regulates cerebral capillary and microvascular function. This equilibrium may be disturbed in pathological conditions such as hypertension, arteriosclerosis, hemorrhagic shock, and diabetes mellitus. 11, 15, 16 It is hypothesized that 2-AG may function as a vasorelaxant that can potentially interact with ET-1 to regulate endothelium-dependent vascular reactivity. 
Materials and Methods

Calcium and Inositol Phosphate Analyses
Endothelium HBECs and HBMECs were prepared and cultivated as previously described. 17 The purity was Ͼ95% as determined by the presence of von Willebrand factor VIII and the absence of markers for astrocytes, microglia, and pericytes. Four cell lines (passages 6 to 13) were used in the present experiments.
The levels of Ca 2ϩ in confluent cultures (24-well plates) were assessed with a 2.5-mol/L fluo 3-AM fluorescent probe as previously described 1 using a CytoFluor II fluorescence multiwell plate reader (PerSeptive Biosystems) with a fluorescein filter pair (excitation 485Ϯ20 nm; emission 530Ϯ25 nm). Ca 2ϩ concentration changes were expressed as fluorescence intensity using the formula: F(experimental)ϪF 0 (initial)/F 0 ϫ100, which normalizes differences in dye loading and cell numbers. A modified technique was used to determine inositol 4,5 biphosphate (IP 2 ), and inositol 1,4,5-triphosphate (IP 3 ) formation was determined as previously described. 18 
Western Blotting
HBECs and HBMECs (35-mm dishes) were exposed to tested agents for the indicated times before lysis in 60 mmol/L Tris-HCl buffer containing 8 mol/L urea and 1% SDS (pH 6.8). Protein was determined using a Bio-Rad protein assay (Bio-Rad Laboratories). Cell proteins (5 g) were electrophoresed (10% SDS-PAGE) and transferred onto 0.45-m pore polyvinylidene difluoride membranes (Millipore). Blots were blocked with 10% goat serum in TNB-T buffer (150 mmol/L Tris, 50 mmol/L NaCl, and 0.05% Tween; pH 7.5) to reduce nonspecific staining and probed overnight with VASP antibody (1:3000) in TNB-T at 4°C and goat anti-mouse HRPconjugated (1:6000). Protein bands were visualized with the enhanced chemiluminescence detection system (Amersham), and relative intensities were quantified by scanning densitometry (Eagle Eye II).
Immunocytochemistry
HBECs and HBMECs (coverslips) were fixed in 3.7% formaldehyde, permeabilized in 0.1% Triton X-100, blocked with 1% BSA, and stained for actin with Texas Red-X phalloidin as previously described. 1 Cells were subsequently incubated with VASP antibody (followed by FITC-goat anti-mouse IgG (1:200). Additional experiments used monoclonal vimentin antibody (1:200) for 1 hour followed by FITC-goat anti-mouse IgG (1:400) for 45 minutes. Coverslips were mounted in Vectashield (Vector Laboratories) and viewed by confocal microscopy (Carl Zeiss).
Results
Effect of 2-AG on ET-1-Induced Ca 2؉ Mobilization
ET-1 dose dependently (EC 50 ϭ20 nmol/L) stimulated intracellular Ca 2ϩ mobilization, and all subsequent experiments used 20 nmol/L ET-1. 2-AG inhibited the ET-1-stimulated intracellular Ca 2ϩ mobilization in a dose-dependent manner ( Figure 1A ). This response was not affected by 10 mol/L L-NAME ( Figure 1B) or 100 mol/L L-NAME (not shown); 10 mol/L indomethacin ( Figure 1B ) or 10 mol/L nordihydroguaiaretic acid (not shown) were also ineffective. The stable 2-AG analog HU313 (arachidonoyl ester) reduced the ET-1-stimulated Ca 2ϩ mobilization in a manner similar to 2-AG (not shown). Treatment with the selective CB1 receptor antagonist SR141716A dose dependently prevented the 2-AG reduction of ET-1-stimulated Ca 2ϩ mobilization ( Figure 1C ). The addition of 2-AG alone gradually increased intracellular Ca 2ϩ content, albeit to significantly lower levels (ie, 8% to 19%) than were observed with ET-1 alone. This effect was not observed in Ca 2ϩ -free medium. Treatment with SR141716A (1 mol/L) inhibited (35%) the 2-AG-induced Ca 2ϩ uptake; SR141716A alone had no effect on Ca 2ϩ uptake. The involvement of G proteins and certain second messengers in the 2-AG-mediated effects on ET-1-stimulated Ca 2ϩ mobilization was next examined. Treatment with 2-AG reduced the Ca 2ϩ mobilization stimulated by 5 mol/L master- , and 100 nmol/L charybdotoxin (CHB) for 15, 30, and 15 minutes, respectively (nϭ5) (E); and 15 and 50 mmol/L K ϩ (nϭ4) (F). * ,**Significant difference from ET-1 alone and from ET-1ϩ50 mol/L 2-AG, respectively; PϽ0.01 by ANOVA with Fisher's protected least-significant difference. L-NAME or Indo alone (B) had no effect on ET-1-stimulated Ca 2ϩ mobilization.
pan by 30%. In addition, 2-AG pretreatment reduced the ET-1-stimulated formation of IP 2 by 70% and IP 3 by 51%. The involvement of second messengers was also tested using the following inhibitors: 200 nmol/L bisindolylmaleimide (BIS); 30 mol/L H7; 5 mol/L H8; and 10 mol/L ODQ. Only treatment with BIS hindered the 2-AG modulation of ET-1-stimulated Ca 2ϩ mobilization ( Figure 1D ), indicating that this effect is partly mediated by PKC and not by cGMP or cAMP kinases.
HBECs were pretreated with agents implicated in the hyperpolarization of the cell membrane (ie, selective inhibitors of K ϩ channel or high [K ϩ ]) to further elucidate the possible pathways responsible for the 2-AG-induced effects. Quinine, apamin, or charybdotoxin partly blocked the 2-AG reduction of ET-1-stimulated intracellular Ca 2ϩ mobilization ( Figure 1E ). Neither BaCl nor ouabain had any effect (not shown). Exposure of HBECs to 15 or 50 mmol/L K ϩ prevented the 2-AG-induced reduction of ET-1-stimulated intracellular Ca ϩ mobilization ( Figure 1F ).
Effect of 2-AG and ET-1 on Cytoskeleton and VASP
2-AG affected the control and the ET-1-stimulated cluster of F-actin ( Figures 2C and 2D ) and vimentin ( Figures 3C and  3D) ; these changes were manifested by the rarefaction of filaments. Pretreatment with either 200 nmol/L BIS ( Figures  2E and 2F ) or 15 mmol/L KCl (not shown) partially prevented the thinning of F-actin; similar effects were observed on vimentin filaments (not shown). Positive staining for the actin binding protein VASP was localized at the terminal segments of F-actin filaments (Figures 2A through 2F ). On the basis of morphology, it is not possible to differentiate the nonphosphorylated and phosphorylated VASP (specific phosphorylated VASP antibodies are currently unavailable). However, VASP phosphorylation, as seen by Western blot analysis (Figure 4 ), clearly demonstrated that 2-AG stimulation is prevented with H8; ET-1 had no effect. Pretreatment with H7 and BIS also had no effect (not shown).
Discussion
The present study indicates that 2-AG reduces the ET-1-stimulated Ca 2ϩ mobilization in HBECs and HBMECs. The results also indicate that the 2-AG-mediated effects may involve the cytoskeleton rearrangement of actin and vimentin filaments. 2-AG is the second arachidonic acid derivate (after anandamide) and is enzymatically hydrolyzed to arachidonic acid. Although these substances structurally resemble eicosanoids, they differ in their biosynthetic pathway. 19 Both the endogenously produced 2-AG and anandamide are ligands for cannabinoid receptors. 3, 4, 10 Studies suggested that these compounds act as neuromodulators and vasomodulators; previous reports demonstrate that these substances may affect the cardiovascular system (hypotension and bradycardia). 4, 9, 20 So far, the vasoactive role of 2-AG as a putative EDRF/ EDHF has not been extensively studied. Reports indicate that anandamide and 2-AG (among other EDRFs/EDHFs) can be released in parallel with NO and, in this way, contribute to endothelium-dependent relaxation. 9 This event may occur through activation (direct or indirect) of vascular smooth muscle K ϩ channels. 11, 21 There are many conflicting reports regarding the effectiveness of anandamide or 2-AG as EDRF/ EDRH agents, their dependence on activation of CB1 receptors, and their mediation of various factors (NO, cyclooxygenase, lipoxygenase). 3, 4, 6, 10, 22, 23 In addition, there is little information regarding possible interaction between these potential vasodilators with vasoconstrictors that could contribute to the maintenance of vascular homeostasis. The observed SR141716A-induced reversal of 2-AG reduction of ET-1-stimulated Ca 2ϩ mobilization and inhibition of 2-AGinduced Ca 2ϩ uptake implicates CB1 receptor in these responses. The lack of Ca 2ϩ response to SR141716A alone supports this conclusion. These observations strongly suggest that HBECs and HBMECs have functional CB1 receptors. Although CB1 receptors were demonstrated in pial vessels, Figure 2 . Cytoskeleton F-actin and VASP in HBECs. Confluent HBECs grown on glass coverslips and processed as described in Materials and Methods and Figure 1 legend were exposed to medium alone (A); ET-1 (20 nmol/L) (B); 2-AG (50 mol/L) (C); 2-AG followed by ET-1 (D); BIS (200 nmol/L) followed by 2-AG (E); and BIS followed by 2-AG followed by ET-1 (F). All cells were stained with phalloidin (red) and VASP (yellow-green) and examined with confocal fluorescence microscope (magnification ϫ63). A, Cells display slender longitudinal and crisscrossing F-actin filaments that form bundles at the margins of overlapping cells; VASP is seen at the focal areas (yellow-green). B, ET-1-treated cells show a marked thickness and prominence of F-actin filaments with terminal caps of VASP. C and D, Both the control (C) and the ET-1-exposed HBECs pretreated with 2-AG (D) display rarefaction of the F-actin filaments capped with VASP. In contrast, HBECs pretreated with BIS display increased F-actin filaments that are more delicate in control cells (E) than in cells treated with 2-AG and ET-1 (F). The localization of VASP is unchanged but overshadowed by the F-actin filaments.
smooth muscle cells derived from cerebral microvessels, and peripheral vascular endothelium, 3, 6, 7, 24 this is the first demonstration of their presence in human brain endothelium.
Investigations indicated that the signal transduction pathway for the 2-AG modulation of ET-1-stimulated Ca 2ϩ mobilization was independent of NO synthase, cyclooxygenase, and lipoxygenase activity (ie, treatment with inhibitors L-NAME, indomethacin, and nordihydroguaiaretic acid was ineffective). The effect of indomethacin is of particular interest. 2-AG, like anandamide, is metabolized to arachidonic acid, and we have observed that the effect of anandamide on ET-1-stimulated Ca 2ϩ mobilization is cyclooxygenasedependent (unpublished data, 2000) . The demonstrated G protein, inositol phosphate hydrolysis, and PKC mediation of 2-AG-induced effects on ET-1-stimulated Ca 2ϩ mobilization indicate that 2-AG affects the pathway distal to the receptor.
The involvement of G protein is supported by studies showing that CB1 receptors have structural features of a G protein-coupled receptor. 5 The additional findings are consistent with the CB1-coupled signal transduction pathways as stipulated by others (see Ameri 5 for review). The capacity of inhibitors of Ca 2ϩ -dependent K ϩ channels or K ϩ ions to modulate 2-AG-induced reduction of ET-1-stimulated Ca 2ϩ mobilization supports the reported involvement of these channels in vasorelaxation induced by EDHF. 11, 21 Because the specificity of some of the inhibitors used is not ensured or well investigated, various inhibitors were used to more accurately characterize the pathways.
The present findings represent a demonstration, for the first time, of the effects of 2-AG on the rarefaction of cytoskeletal filaments and the phosphorylation of the actin binding protein VASP. Although the exact mechanisms responsible for these effects are unknown, it is intriguing that the substances that phosphorylate VASP also rarefied the actin and vimentin assembly. Interestingly, similar results were observed with NO. 1, 25 VASP has been associated with actin filaments and local adhesion 26 and was suggested to impede or promote actin assembly. 27 These activities may involve substances known to elevate either cGMP or cAMP (ie, prostaglandin E 2 , NO donors, respectively) because they stimulate phosphorylation of VASP. 26, 28 The data indicate that 2-AG, a cannabinoid agonist, counteracts ET-1-induced cerebral capillary and microvascular endothelial responses (ie, Ca 2ϩ mobilization and cytoskeleton rearrangement). The inhibition of this response by a CB1 receptor antagonist indicates that functional cannabinoid CB1 receptors may be expressed by these cells. The results represent the first direct evidence of a functional interaction between 2-AG and ET-1 and provide a potential alternative pathway for abrogating ET-1-inducible, endotheliumdependent capillary, and/or microvascular effects in the brain. Samples from HBECs treated with indicated compounds were analyzed for VASP, as described in Materials and Methods. The shift from 46 to 50 kDa indicates the apparent phosphorylation of VASP and is expressed as a ratio of the respective densities. The levels of increased phosphorylation compared with control for this representative experiment were 0.5-fold (ET-1), 3.5-fold (2-AG), 3.9-fold (2-AGϩET-1), and 0.9-fold (2-AGϩH8).
